RATIO: Rational Approach To Immuno-Oncology
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Metastatic Melanoma
Related studies linked through entity extraction aliases.
Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 2 Study to Assess the Safety and Efficacy of IMO-2125 With 8 mg Ipilimumab in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Sequential Combo Immuno and Target Therapy (SECOMBIT) Study
- Status
- COMPLETED
- Phase
- PHASE2
Immune Modulation Study in Patients With Metastatic Melanoma Treated With Anti-PD1 Monoclonal Antibodies
- Status
- COMPLETED
- Phase
- PHASE4
Study Comparing Pembrolizumab With Dual MAPK Pathway Inhibition Plus Pembrolizumab in Melanoma Patients
- Status
- UNKNOWN
- Phase
- PHASE2
A Study Investigating SGI-110 in Combination With Ipilimumab in Unresectable or Metastatic Melanoma Patients
- Status
- UNKNOWN
- Phase
- PHASE1
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
In Vivo Persistence of Adoptively-Transferred TIL Cultured With Akti in People With Metastatic Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Adoptive Transfer of Specific Melanoma Antigens CD8+ T Cells in Metastatic Melanoma Patients: a Phase I/II Study
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Vemurafenib Plus Cobimetinib in Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Radiotherapy & Combi in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Peginterferon and TIL Therapy for Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Using Tumor-Reactive Autologous Tumor Infiltrating Lymphocytes (TIL) in Metastatic Melanomas
- Status
- TERMINATED
- Phase
- PHASE2
Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2